Filing Details
- Accession Number:
- 0001104659-19-002543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-18 20:58:12
- Reporting Period:
- 2019-01-17
- Accepted Time:
- 2019-01-18 20:58:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742806 | Vickesh Myer | C/O Editas Medicine, Inc. 11 Hurley Street Cambridge MA 02141 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-17 | 3,000 | $0.65 | 3,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-17 | 3,000 | $26.18 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-01-18 | 4,000 | $11.21 | 4,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-18 | 4,000 | $26.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-01-17 | 3,000 | $0.00 | 3,000 | $0.65 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-01-18 | 4,000 | $0.00 | 4,000 | $11.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 79,307 | 2025-04-29 | No | 4 | M | Direct | |
| 52,897 | 2025-10-29 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017.
- This transaction was executed in multiple trades at prices ranging from $26.03 to $26.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
- This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019.
- This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019.
Billionaire Hedge Funds
